Artelo Biosciences, Inc. (ARTL) Tops Q1 EPS by 13c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q1 EPS of ($0.78), $0.13 better than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
• Albemarle names Max Hood as chief accounting officer